| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
111,035,000 |
| Market
Cap: |
832.76(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.65 - $9.14 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 5.3 |
| Insider 3/6 Months : 5.9 |
|
| Guru Rank Number : 614 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile MiMedx Group is a wound care and a therapeutic biologics company, developing and distributing placental tissue allografts. Co. provides products in the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Co.'s biomaterial platform technologies include AmnioFix®, EpiFix®, EpiCord®, AmnioCord® and AmnioFill®. AmnioFix and EpiFix are its tissue allografts derived from the amnion and chorion layers of the human placental membrane. EpiCord and AmnioCord are tissue allografts derived from umbilical cord tissue. AmnioFill is a placental connective tissue matrix, derived from the placental disc and other placental tissue.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
5,000 |
105,000 |
105,000 |
| Total Buy Value |
$0 |
$35,787 |
$676,221 |
$676,221 |
| Total People Bought |
0 |
1 |
2 |
2 |
| Total Buy Transactions |
0 |
1 |
3 |
3 |
| Total Shares Sold |
82,188 |
82,188 |
172,426 |
499,684 |
| Total Sell Value |
$659,218 |
$659,218 |
$1,153,656 |
$2,406,837 |
| Total People Sold |
2 |
2 |
5 |
9 |
| Total Sell Transactions |
5 |
5 |
13 |
38 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wright Timothy R |
Chief Executive Officer |
• • – |
2022-03-08 |
4 |
S |
$4.86 |
$221,624 |
D/D |
(45,611) |
1,220,645 |
|
30% |
|
| Carlson Peter M |
Chief Financial Officer |
• – – |
2022-03-08 |
4 |
S |
$4.86 |
$52,200 |
D/D |
(10,743) |
382,698 |
|
30% |
|
| Stein Robert Benjamin |
EVP, Research and Development |
• – – |
2022-03-08 |
4 |
S |
$4.86 |
$56,714 |
D/D |
(11,672) |
170,034 |
|
30% |
|
| Phelan William Lawrence |
Chief Accounting Officer |
• – – |
2022-03-08 |
4 |
S |
$4.86 |
$15,879 |
D/D |
(3,268) |
97,360 |
|
30% |
|
| Carlson Peter M |
Chief Financial Officer |
• – – |
2022-02-25 |
4 |
S |
$4.83 |
$84,079 |
D/D |
(17,400) |
393,441 |
|
24% |
|
| Graves Mark |
SVP & Chief Compliance Officer |
• – – |
2022-02-24 |
4 |
S |
$4.32 |
$19,539 |
D/D |
(4,525) |
92,248 |
|
23% |
|
| Wright Timothy R |
Chief Executive Officer |
• • – |
2022-02-23 |
4 |
S |
$4.31 |
$263,075 |
D/D |
(61,000) |
1,266,256 |
|
15% |
|
| Hulse William Frank Iv |
General Counsel |
• – – |
2022-02-23 |
4 |
S |
$4.41 |
$59,535 |
D/D |
(13,500) |
196,335 |
|
15% |
|
| Turner Scott M |
SVP, Operations & Procurement |
• – – |
2022-02-23 |
4 |
S |
$4.50 |
$25,821 |
D/D |
(5,738) |
174,586 |
|
15% |
|
| Stein Robert Benjamin |
EVP, Research and Development |
• – – |
2021-08-16 |
4 |
S |
$11.85 |
$110,968 |
D/D |
(9,362) |
181,706 |
|
48% |
|
| Carlson Peter M |
Chief Financial Officer |
• – – |
2021-07-28 |
4 |
D |
$12.26 |
$162,739 |
D/D |
(13,274) |
410,841 |
|
- |
|
| Carlson Peter M |
Chief Financial Officer |
• – – |
2021-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
35,212 |
424,115 |
|
- |
|
| Graves Mark |
SVP & Chief Compliance Officer |
• – – |
2021-07-27 |
4 |
D |
$12.07 |
$18,165 |
D/D |
(1,505) |
98,265 |
|
- |
|
| Wright Timothy R |
Chief Executive Officer |
• • – |
2021-06-08 |
4 |
S |
$0.00 |
$0 |
D/D |
(101,957) |
1,327,256 |
|
39% |
|
| Giuliani Michael J |
Director |
– • – |
2021-05-27 |
4 |
A |
$10.26 |
$174,995 |
D/D |
17,056 |
50,579 |
|
- |
|
| Behrens M Kathleen |
Director |
– • – |
2021-05-27 |
4 |
A |
$10.26 |
$174,995 |
D/D |
17,056 |
81,427 |
|
- |
|
| Newton Todd |
Director |
– • – |
2021-05-27 |
4 |
A |
$10.26 |
$174,995 |
D/D |
17,056 |
81,427 |
|
- |
|
| Hawkins William A |
Director |
– • – |
2021-05-27 |
4 |
A |
$10.26 |
$174,995 |
D/D |
17,056 |
72,674 |
|
- |
|
| Bierman James L |
Director |
– • – |
2021-05-27 |
4 |
A |
$10.26 |
$174,995 |
D/D |
17,056 |
81,427 |
|
- |
|
| Laurencin Cato T |
Director |
– • – |
2021-05-27 |
4 |
A |
$10.26 |
$174,995 |
D/D |
17,056 |
50,579 |
|
- |
|
| Gardner Phyllis |
Director |
– • – |
2021-05-27 |
4 |
A |
$10.26 |
$174,995 |
D/D |
17,056 |
37,479 |
|
- |
|
| Phelan William Lawrence |
Chief Accounting Officer |
• – – |
2021-05-01 |
4 |
D |
$9.70 |
$52,700 |
D/D |
(5,433) |
92,154 |
|
- |
|
| Gardner Phyllis |
Director |
– • – |
2021-04-28 |
4 |
A |
$10.71 |
$218,730 |
D/D |
20,423 |
20,423 |
|
- |
|
| Turner Scott M |
SVP, Operations & Procurement |
• – – |
2021-04-26 |
4 |
D |
$10.63 |
$55,531 |
D/D |
(5,224) |
180,324 |
|
- |
|
| Graves Mark |
SVP & Chief Compliance Officer |
• – – |
2021-04-26 |
4 |
D |
$10.63 |
$36,854 |
D/D |
(3,467) |
99,770 |
|
- |
|
328 Records found
|
|
Page 4 of 14 |
|
|
0.19 (2.6%) 
